Oxford Biomedica (UK) Ltd., part of Oxford Biomedica Plc, is a company headquartered in Oxford, UK. The firm develops novel gene therapy products and treatment for cystic fibrosis.

Servier are driven by the belief in the excellence of their profession. Theirs is a research-based organization, fulfilling a basic need and dedicated to the future.

Asterias Biotherapeutics is a development-stage biotechnology company pioneering the field of regenerative medicine. It focuses on the development of therapeutic products to treat neurology, oncology, cardiology, metabolic diseases, ophthalmology, orthopedics, and blood and vascular diseases. It is also developing human embryonic stem cell programs, including cell lines and a Phase I clinical trial in patients with acute spinal cord injury; intellectual property related to its autologous cellular immunotherapy program, including a Phase I/II clinical trial of autologous immunotherapy in patients with acute myelogenous leukemia; and non-therapeutic applications of pluripotent stem cells, such as cellular assay products for use in drug development and toxicity screening. The company was formerly known as BioTime Acquisition Corporation and changed its name to Asterias Biotherapeutics, Inc. in March 2013. Asterias Biotherapeutics, Inc. was founded in 2012 and is based in Menlo Park, California.

Reliance Life Sciences is a diverse and integrated biotechnology initiative of the Reliance Group of companies. The Reliance Group is India’s largest private sector enterprise, with annual revenues of US$ 66.8 billion. The Group’s activities span oil and gas exploration and production, petroleum refining, petrochemicals, polyester, plastics, organized retailing and telecom. The Group’s flagship company Reliance Industries Limited is the largest private sector company and a Fortune Global 500 company. Reliance Life Sciences is part of the Promoter Group of Reliance Industries Limited. RLS was established to develop business opportunities in medical biotechnology with key initiatives in biopharmaceuticals, pharmaceuticals, regenerative medicine, clinical research and molecular diagnostics.

Kanglin Biotechnology (Hangzhou) Co., Ltd., established on 2015-08-07, Business scope includes technology development,Technical Services,technical consulting:Biotechnology,medical technology,biological reagent(In addition to drugs,Hazardous chemicals and precursor chemicals);drug development;wholesale,retail:Laboratory equipment and consumables(Removal of hazardous chemicals and precursor chemicals),laboratory equipment,equipment.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Part of Syros Pharmaceuticals, Inc., Tyme, Inc. is an American company located in Wilmington, DE, that provides research and development services focused on developing drug candidates for the treatment of cancer. Steve Hoffman is the CEO, in this role since 2013. Tyme Technologies, Inc., now a subsidiary of Syros Pharmaceuticals, Inc. acquired Tyme, Inc. on March 05, 2015.\nThe company says this about itself: Tyme Inc. is a clinical-stage bio technology company developing cancer therapeutics that are intended to be broadly effective across tumor types and have low toxicity profiles. Unlike targeted therapies that attempt to regulate specific mutations within cancer, the Company��s therapeutic approach is designed to take advantage of a cancer cell��s innate metabolic weaknesses to compromise its defenses, leading to cell death through oxidative stress and exposure to the body��s natural immune system. Tyme��s lead clinical program, SM-88, is a first-in-class combination therapy in Phase II development for prostate cancer, and the Company is preparing to initiate an additional Phase II clinical trial in pancreatic cancer.

Rhone Poulenc Rorer, a subsidiary of Solvay SA, is a French company that manufactures and distributs pharmaceutical products.

McLean Hospital was founded on Feb. 25, 1811, through a charter granted by the Massachusetts Legislature for the “Massachusetts General Hospital Corporation.” From its inception, the Corporation intended to treat both physical and mental illnesses, with a separate facility for each. Fundraising campaigns were held between 1812 and 1816, and a majority of the contributors earmarked their donations for the establishment of a facility to treat mental illnesses. McLean Hospital is dedicated to improving the lives of people and families affected by psychiatric illness. McLean Hospital is a comprehensive mental health care facility committed to providing a full range of high quality, cost effective, mental health services. At McLean Hospital, their staff, faculty, volunteers and supporters are dedicated to improving the lives of people and families affected by psychiatric illness. As the largest psychiatric affiliate of Harvard Medical School, McLean has been meeting the needs of individuals and families with psychiatric illness since their founding in 1811. McLean Hospital's staff of more than 1,900 caring and compassionate individuals are each dedicated to improving the lives of people living with mental illness and their families. McLean Hospital is an affiliate of Harvard Medical School and a member of Partners Healthcare. McLean Hospital is the largest psychiatric teaching facility of Harvard Medical School.

CellResearch Corporation was founded in Singapore in 2002 by scientists with a keen interest and expertise in Cell Biology. It’s original remit was to provide skin and scar cells to laboratories around the world for research, as well as to perform contract research for cell laboratories internationally. In 2004, our scientists isolated Epithelial and Mesenchymal Stem Cells from the Umbilical Cord Lining Membrane. This novel and significant discovery was put up for intellectual property protection, and to date we have patents granted in multiple strategic key territories around the world. The umbilical cord lining membrane is now known to be the richest source of stem cells in the body, and both epithelial and mesenchymal stem cells are being researched intensively with collaborators all around the world to exploit their potential for downstream medical therapy. Considerable headway has already been achieved, and we are due shortly to start USFDA Clinical Trials with our collaborators in the USA, leading to a therapy to accelerate wound healing. To maximise future Cord Lining Stem Cell use, CellResearch Corporation feels that the membrane from which the cells are derived should be stored. Today we license our proprietary technology to partners who bank Cord Lining Membrane in various territories around the world. Our extensive experience with Cord Lining Stem Cells has taught us much, and we have been able to utilise this knowledge to produce a ground breaking cosmeceutical line called CALECIM® which has been observed to improve the skin appearance after topical application.

Geron is a biotechnology company that specializes in developing blood cancer treatments for hematologic malignancies. The company's Imetelstat, an investigational first-in-class telomerase inhibitor, harnesses Nobel Prize-winning science in a treatment that may change the underlying course of these diseases. Geron was established in 1990 and is headquartered in Foster City, California.

Layton BioScience

NsGene A/S identifies neurotrophic proteins with therapeutic effects in the nervous system. It is a biotechnology company that focuses primarily on neurodegenerative disorders. The firm provides technologies that target protein therapeutics across the blood-brain-barrier and directly to diseased nerve cells. It develops therapeutic products for multiple indications with high medical needs including Alzheimer’s disease, Parkinson's disease, deafness, neuropathic pain, epilepsy, cortico-basal degeneration, and Huntington’s disease. The company was founded by Lars Ulrik Wahlberg and Teit Eliot Johansen in 1999 and is headquartered in Ballerup, Denmark.

Kyoto Biken Laboratories, Inc. manufactures veterinary vaccines. It specializes in bovine, porcine, poultry, and plant vaccines. The firm��s business activities include research and development, manufacturing, laboratory diagnosis for field specimens, quality control, after sales validation, and packaging and shipment. The company was founded in June 1948 and is headquartered in Uji, Japan.

G.D. Searle, LLC is a wholly owned trademark of Pfizer. It is currently used mainly as a distribution trademark for various pharmaceuticals that were developed by G. D. Searle & Company (often referred to as Searle). Prior to its 1985 merger with Monsanto, Searle was a company focusing on life sciences, specifically pharmaceuticals, agriculture, and animal health.

The Rural Development Administration (Korean: 농촌진흥청; Hanja: 農村振興廳, RDA) is one of an agriculture organizations in South Korea and is run under the Ministry of Agriculture, Food and Rural Affairs. The headquarters are in Wansan-gu, Jeonju.